Impact of Radiofrequency Ablation and Antiarrhythmic Medications on the Quality of Life of Patients with Supraventricular Tachycardias: Preliminary Validation of the Greek Version of the Umea22 (U22) Questionnaire
Table 3
SF-36 measures at baseline and follow-up.
Measure
Group
Baseline mean±SD
Follow-up mean±SD
Change mean±SD
ES
P∗
PF
A
66.70±26.07
87.05±20.28
20.35±21.94
0.78
<0.0001
B
57.25±24.31
59.25±21.35
2.00±20.81
0.08
<0.0001
RP
A
40.75±32.69
78.50±32.38
37.75±37.01
1.15
<0.0001
B
36.25±29.39
29.38±25.87
-6.87±35.35
-0.23
0.249
BP
A
76.15±23.53
92.13±17.11
15.98±18.94
0.68
<0.0001
B
75.38±23.01
68.16±18.58
-7.22±22.75
-0.30
0.007
GH
A
69.09±18.30
79.96±18.55
10.87±13.95
0.59
<0.0001
B
61.38±17.89
49.83±23.25
-11.55±22.27
-0.65
0.005
VT
A
48.90±7.96
59.05±9.66
10.15±8.72
1.28
<0.0001
B
47.50±6.79
47.13±7.24
-0.37±12.06
-0.05
0.002
SF
A
57.38±26.66
82.25±22.56
24.87±27.27
0.93
<0.0001
B
48.44±26.88
43.44±25.63
-5.00±22.07
-0.19
<0.0001
RE
A
41.00±33.79
77.00±32.38
36.00±44.36
1.07
<0.0001
B
40.00±34.76
35.83±28.63
-4.17±38.63
-0.12
0.093
MH
A
50.80±9.95
58.44±11.45
7.64±9.52
0.77
<0.0001
B
50.00±9.53
47.60±8.39
-2.40±9.01
-0.25
0.001
PCS
A
67.41±18.06
84.73±16.46
17.32±13.84
0.96
<0.0001
B
60.58±18.27
55.20±17.26
-5.38±17.19
-0.29
<0.0001
MCS
A
50.54±8.12
63.05±9.97
12.51±9.27
1.54
<0.0001
B
48.57±7.88
46.21±9.02
-2.36±9.67
-0.30
0.026
Total score
A
61.54±12.35
75.29±11.08
13.75±9.70
1.11
<0.0001
B
54.47±12.19
50.62±12.24
-3.85±12.16
-0.32
0.001
signed rank test. ES=effect size, PF = physical functioning, RP = role physical, BP = bodily pain, GH = general health, VT = vitality, SF = social functioning, RE = role emotional, MH = mental health, PCS= physical component scale, MCS= mental component scale.
